Compare

TriNet/$TNET

1D1W1M3M6MYTD1Y5YMAX

About TriNet

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
Ticker
$TNET
Sector
Business services
Primary listing
NYSE
Employees
298,894

TriNet Metrics

BasicAdvanced
$3.1B
18.15
$3.67
0.98
$1.15
1.74%

What the Analysts think about TriNet

Analyst ratings (Buy, Hold, Sell) for TriNet stock.
Analyst projections of the future price of TriNet stock.

Bulls say / Bears say

The insurance cost ratio improved to 89% in Q3 from 90% a year earlier, and TriNet expects to finish 2026 at the favourable end of its 88.5%–89.5% range. Management now expects adjusted EPS at the top end of guidance, suggesting better pricing and claims control are supporting earnings. (TriNet)
New-sales ACV grew by a mid-single-digit rate in Q3, and management forecast high-single-digit growth in Q4. Retention also improved, offering a route to stabilise worksite employee numbers after the repricing-related losses. (Stock Analysis)
TriNet is adding leave, recruiting and spending tools to its HR platform, while expanding AI support. Nearly 60% of employee-initiated chats were resolved by AI in Q3, and management said its older-case backlog fell by over 60%, which could improve service efficiency and make the offering more valuable to clients. (TriNet, Stock Analysis)
The business is still losing scale: Q3 worksite employees fell 11% year on year to about 295,000, while total revenue declined 5%. That shrinking base puts pressure on future growth even as pricing offsets some of the volume decline. (TriNet)
Profitability weakened year on year in Q3: adjusted net income fell 20%, adjusted EBITDA fell 11%, and EBITDA margin narrowed to 7.6% from 8.2%. The strong earnings outlook therefore sits alongside a softer quarterly profit comparison. (TriNet)
Medical cost trends remain in the high single digits, and TriNet said Q3 pharmaceutical cost trends rose from the first half and may normalise further. Management cautioned that future high-cost drugs could put pressure on insurance margins, making the recent improvement in claims costs vulnerable to reversal. (Stock Analysis)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.

TriNet Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

TriNet Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.